|
|
||||||||
Radiology, Vol 121, 375-377, Copyright © 1976 by Radiological Society of North America
REVIEWS |
ME Phelps and DE Kuhl
The use of contrast material and computed tomography (CT) to measure cerebral blood volume (CBV) is valid only if the agent does not egress into cerebral tissue. Since disruption of the blood/brain barrier is common in cerebral disease states, this raises serious doubt as to the validity of this technique. Studies in experimental animals and patients with cerebral lesions demonstrate that contrast material does egress into the extravascular space. In normal brain tissue, contrast enhancement is comparable to the error in CT. Contrast material also causes transient changes in autoregulation, blood pressure, cerebral blood flow, and CBV.
This article has been cited by other articles:
![]() |
Y. Okudaira, K. Bandoh, H. Arai, and K. Sato Evaluation of the Acetazolamide Test : Vasoreactivity and Cerebral Blood Volume Stroke, July 1, 1995; 26(7): 1234 - 1239. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |